PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT
0402.307.894 · rovalta.com · 22/09/2026
PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT
Overview
What does PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT do?
PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT is a Cooperative society incorporated in 1913. Its registered office is in Thimister-Clermont. It employs on average 340,1 ETP workers (FTE).
4890 Thimister-Clermont · WallonieSee on map
Joint committees (1)
- 313
Trend over 20 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||||||||||
| Revenue | 109,5 M € | +6.4% | 102,9 M € | +20.0% | 85,8 M € | +5.8% | 81,1 M € | +11.7% | 72,5 M € | +6.8% | 67,9 M € | +6.6% | 63,7 M € | +3.3% | 61,7 M € | +2.8% | 60 M € | -2.5% | 61,5 M € | +3.3% | 59,5 M € | +3.7% | 57,4 M € | -0.5% | 57,7 M € | +0.3% | 57,6 M € | +3.4% | 55,6 M € | +4.1% | 53,4 M € | +1.4% | 52,7 M € | +3.1% | 51,1 M € | +6.6% | 48 M € | +7.3% | 44,7 M € |
| EBITDA | 4,4 M € | -12.5% | 5,1 M € | +29.5% | 3,9 M € | +10.2% | 3,6 M € | +24.4% | 2,9 M € | -0.7% | 2,9 M € | +1.6% | 2,8 M € | +18.8% | 2,4 M € | -2.2% | 2,4 M € | -2.5% | 2,5 M € | +10.1% | 2,3 M € | +11.2% | 2 M € | -20.7% | 2,6 M € | +33.2% | 1,9 M € | -11.5% | 2,2 M € | +2.1% | 2,1 M € | -11.5% | 2,4 M € | -8.6% | 2,6 M € | -4.1% | 2,8 M € | +25.8% | 2,2 M € |
| Operating result | 2,7 M € | -9.2% | 3 M € | +35.2% | 2,2 M € | +42.2% | 1,5 M € | +29.2% | 1,2 M € | +23.8% | 963,8 k € | -15.3% | 1,1 M € | +48.6% | 765,5 k € | -19.3% | 948 k € | -22.2% | 1,2 M € | +32.3% | 920,6 k € | +46.9% | 626,7 k € | -48.7% | 1,2 M € | +67.0% | 730,9 k € | -32.4% | 1,1 M € | -6.1% | 1,2 M € | -22.7% | 1,5 M € | -18.2% | 1,8 M € | -10.2% | 2 M € | +29.8% | 1,6 M € |
| Net result | 3,8 M € | -26.8% | 5,2 M € | +386% | 1,1 M € | +62.1% | 654,4 k € | -88.4% | 5,6 M € | +1346% | 388,5 k € | -6.6% | 415,9 k € | +168% | 155 k € | -65.6% | 450,1 k € | +24.9% | 360,4 k € | +321% | 85,7 k € | -38.6% | 139,5 k € | -61.0% | 357,6 k € | +344% | 80,6 k € | -75.5% | 329 k € | +269% | 89,2 k € | -78.4% | 412,8 k € | -35.6% | 641,5 k € | -8.6% | 702,1 k € | +95.9% | 358,4 k € |
| Balance sheet | |||||||||||||||||||||||||||||||||||||||
| Equity | 24 M € | +18.6% | 20,2 M € | +47.2% | 13,7 M € | +8.3% | 12,7 M € | +5.4% | 12 M € | +87.4% | 6,4 M € | +6.3% | 6 M € | +7.2% | 5,6 M € | +2.6% | 5,5 M € | +8.7% | 5,1 M € | +7.4% | 4,7 M € | +1.6% | 4,6 M € | +2.9% | 4,5 M € | +8.4% | 4,1 M € | +1.7% | 4,1 M € | +8.5% | 3,8 M € | +2.0% | 3,7 M € | +12.1% | 3,3 M € | +23.6% | 2,7 M € | +27.1% | 2,1 M € |
| Total assets | 73,8 M € | +17.0% | 63,1 M € | +21.0% | 52,1 M € | +1.4% | 51,4 M € | +2.5% | 50,1 M € | +22.6% | 40,9 M € | +11.8% | 36,6 M € | +0.1% | 36,5 M € | +7.2% | 34,1 M € | +2.0% | 33,4 M € | +1.2% | 33 M € | +4.7% | 31,5 M € | +7.1% | 29,4 M € | -1.0% | 29,7 M € | -0.2% | 29,8 M € | +5.0% | 28,4 M € | +0.9% | 28,1 M € | +10.4% | 25,5 M € | +8.7% | 23,4 M € | +3.1% | 22,7 M € |
| Cash | 512,7 k € | -3.8% | 533,2 k € | -0.9% | 538,1 k € | +13.5% | 474,3 k € | +18.1% | 401,7 k € | +30.6% | 307,6 k € | -13.0% | 353,7 k € | +2.6% | 344,8 k € | -35.5% | 534,6 k € | +54.1% | 347 k € | +11.1% | 312,4 k € | +4.1% | 300,2 k € | -0.6% | 302 k € | -16.6% | 362,1 k € | +2.3% | 353,8 k € | +23.3% | 287 k € | +8.7% | 264 k € | -2.1% | 269,7 k € | -6.8% | 289,5 k € | -28.3% | 403,6 k € |
| Debts | 48,7 M € | +17.4% | 41,5 M € | +11.2% | 37,4 M € | -1.4% | 37,9 M € | +1.6% | 37,3 M € | +11.2% | 33,5 M € | +12.8% | 29,7 M € | -1.6% | 30,2 M € | +8.3% | 27,9 M € | +0.4% | 27,8 M € | +0.9% | 27,6 M € | +5.0% | 26,2 M € | +8.3% | 24,2 M € | -2.8% | 24,9 M € | -0.2% | 25 M € | +4.4% | 23,9 M € | +0.4% | 23,8 M € | +10.6% | 21,5 M € | +6.8% | 20,1 M € | +0.1% | 20,1 M € |
| Other | |||||||||||||||||||||||||||||||||||||||
| Workforce | 340,1 ETP | +2.8% | 330,7 ETP | -1.3% | 334,9 ETP | +6.2% | 315,4 ETP | +7.6% | 293,0 ETP | +3.4% | 283,4 ETP | +1.9% | 278,0 ETP | +1.2% | 274,7 ETP | +1.2% | 271,5 ETP | +2.8% | 264,2 ETP | -0.1% | 264,4 ETP | +5.0% | 251,8 ETP | +4.0% | 242,2 ETP | +0.3% | 241,4 ETP | +1.7% | 237,4 ETP | +2.7% | 231,1 ETP | +0.7% | 229,5 ETP | -5.2% | 242,2 ETP | +0.9% | 240,0 ETP | +1.2% | 237,2 ETP |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 8 active · 40 ended
Active mandates
Ended mandates
Other companies at this address
| Company | CBE no. |
|---|---|
GENERATION 2000● Active | 0432.862.104 |
La Grande Pharmacie● Active | 0402.353.129 |
PHARMACIE DOUCET-STAS● Active | 0859.769.297 |
PHARMACIE LARDINOIS● Active | 0420.259.329 |
PHARMAEXPRESS● Active | 0743.800.651 |
PHARMA FUTUR● Active | 0787.394.827 |
SANTIS PHARMA● Active | 0421.562.592 |
V-IMMO● Active | 0461.767.213 |
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | m120-f-p |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 12/05/2026 | 19/05/2025 | 14/05/2024 | 25/04/2023 | 29/04/2022 | 11/05/2021 |
| General meeting | 11/05/2026 | 12/05/2025 | 13/05/2024 | 24/04/2023 | 25/04/2022 | 26/04/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
76 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2025 | 11/05/2026 | 12/05/2026 | French | |
| m120-f-p | 31/12/2025 | 11/05/2026 | 12/05/2026 | French | |
| Full model | 31/12/2024 | 12/05/2025 | 19/05/2025 | French | |
| m120-f-p | 31/12/2024 | 12/05/2025 | 19/05/2025 | French | |
| Full model | 31/12/2023 | 13/05/2024 | 14/05/2024 | French | |
| m120-f-p | 31/12/2023 | 13/05/2024 | 14/05/2024 | French | |
| Full model | 31/12/2022 | 24/04/2023 | 25/04/2023 | French | |
| m120-f-p | 31/12/2022 | 24/04/2023 | 25/04/2023 | French | |
| Full model | 31/12/2021 | 25/04/2022 | 29/04/2022 | French | |
| m120-f-p | 31/12/2021 | 25/04/2022 | 03/05/2022 | French | |
| Full model | 31/12/2020 | 26/04/2021 | 10/05/2021 | French | |
| m120-f-p | 31/12/2020 | 26/04/2021 | 11/05/2021 | French | |
| Full model | 31/12/2019 | 27/04/2020 | 16/06/2020 | French | |
| m120-f-p | 31/12/2019 | 27/04/2020 | 16/06/2020 | French | |
| Full model | 31/12/2018 | 29/04/2019 | 07/05/2019 | French | |
| m120-f-p | 31/12/2018 | 29/04/2019 | 07/05/2019 | French | |
| Full model | 31/12/2017 | 23/04/2018 | 25/04/2018 | French | |
| m120-f-p | 31/12/2017 | 23/04/2018 | 25/04/2018 | French | |
| Full model | 31/12/2016 | 24/04/2017 | 25/04/2017 | French | |
| m120-f-p | 31/12/2016 | 24/04/2017 | 02/05/2017 | French | |
| Full model | 31/12/2015 | 25/04/2016 | 26/04/2016 | French | |
| m120-f-p | 31/12/2015 | 25/04/2016 | 26/04/2016 | French | |
| Full model | 31/12/2014 | 27/04/2015 | 29/04/2015 | French | |
| m120-f-p | 31/12/2014 | 27/04/2015 | 07/05/2015 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 10 M€ and 25 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 8 active · 40 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Registered office09/09/2026CHANGEMENT DE SIEGE SOCIAL
- Restructuring31/10/2025STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Restructuring09/09/2025RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...) - DIVERS
- Mandates16/06/2025DEMISSIONS, NOMINATIONS
- Capital / shares27/05/2024CAPITAL, ACTIONS
- Other22/12/2023STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
- Mandates07/07/2022STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - DENOMINATION - OBJET - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS - ASSEMBLEE GENERALE
- Mandates06/07/2022DEMISSIONS, NOMINATIONS
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 20253,8 M €↓
- 01/07/2025autre
- 12/05/2025reconductionMonique SCHMITZ — administrateur
- 12/05/2025reconductionPhilippe GEORIS — administrateur
- 12/05/2025reconductionPierre DETHIER — administrateur
- 12/05/2025reconductionMadeleine GROSCH-HENNES — administrateur
- 12/05/2025nominationOlivier BUSTIN — Administrateur
- 12/05/2025reconductionCatherine GREGOIRE — représentant permanent (commissaire)
- 12/05/2025nominationPhilippe GEORIS — Président du Conseil d'Administration
- 2024Annual accounts 20245,2 M €↑
- 22/04/2024augmentation_capital
- 2023Annual accounts 20231,1 M €↑
- 2022Annual accounts 2022654,4 k €↓
- 25/04/2022reconductionCatherine DAUBY — administrateur
- 25/04/2022reconductionBernard LEMARCHAND — administrateur
- 25/04/2022reconductionMarc BREYER — administrateur
- 25/04/2022nominationHélène GORRIA — délégué à la gestion journalière
- 25/04/2022nominationPierre LAFLEUR — délégué à la gestion journalière
- 25/04/2022nominationCatherine GREGOIRE — représentant permanent (commissaire)
- 25/04/2022nominationPhilippe GEORIS — Président du Conseil d'Administration
- 2022Name changePHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT
- 2021Annual accounts 20215,6 M €↑
- 2020Annual accounts 2020388,5 k €↓
- 2019Annual accounts 2019415,9 k €↑
- 2018Annual accounts 2018155 k €↓
- 2017Annual accounts 2017450,1 k €↑
- 2016Annual accounts 2016360,4 k €↑
- 2015Annual accounts 201585,7 k €↓
- 2014Annual accounts 2014139,5 k €↓
- 2013Annual accounts 2013357,6 k €↑
- 2012Annual accounts 201280,6 k €↓
- 2011Annual accounts 2011329 k €↑
- 2010Annual accounts 201089,2 k €↓
- 2009Annual accounts 2009412,8 k €↓
- 2008Annual accounts 2008641,5 k €↓
- 2008Name changeSOCIETE ROYALE COOPERATIVE A RESPONSABILITE LIMITEE DES PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT
- 2007Annual accounts 2007702,1 k €↑
- 2006Annual accounts 2006358,4 k €
- 26/06/1913IncorporationCooperative society